39 Grants (Page 1 of 2)
2023
Translation initiation factors driving persistence of Toxoplasma gondii bradyzoites in neurons
Sullivan, William J and WEK, RONALD C
National Institutes of Health (NIH), National Institute of Allergy and Infectious Diseases (NIAID) (ID: 1R01AI172752-01), $459,038USD, 2022-12-08 -- 2027-11-30
2021
Regulation and Function of Integrated Stress Response
WEK, RONALD C
National Institutes of Health (NIH), National Institute of General Medical Sciences (NIGMS) (ID: 5R35GM136331-02), $386,355USD, 2020-05-01 -- 2025-04-30
2020
Regulation and Function of Integrated Stress Response
WEK, RONALD C
National Institutes of Health (NIH), National Institute of General Medical Sciences (NIGMS) (ID: 1R35GM136331-01), $386,355USD, 2020-05-01 -- 2025-04-30
 
Translational control during stage conversion of Toxoplasma, an opportunistic infection of HIV/AIDS
SULLIVAN, WILLIAM J and WEK, RONALD C
National Institutes of Health (NIH), National Institute of Allergy and Infectious Diseases (NIAID) (ID: 5R01AI124723-05), $393,534USD, 2016-03-01 -- 2021-02-28
2019
Metabolic stress responses and eIF2 kinase GCN2
WEK, RONALD C
National Institutes of Health (NIH), National Institute of General Medical Sciences (NIGMS) (ID: 5R01GM049164-25), $392,371USD, 04/01/1993 -- 04/30/2020
 
Translational control during stage conversion of Toxoplasma, an opportunistic infection of HIV/AIDS
SULLIVAN, WILLIAM J and WEK, RONALD C
National Institutes of Health (NIH), National Institute of Allergy and Infectious Diseases (NIAID) (ID: 5R01AI124723-04), $393,534USD, 03/01/2016 -- 02/28/2021
2018
Metabolic stress responses and eIF2 kinase GCN2
WEK, RONALD C
National Institutes of Health (NIH), National Institute of General Medical Sciences (NIGMS) (ID: 3R01GM049164-24S1), $199,487USD, 04/01/1993 -- 04/30/2020
 
Metabolic stress responses and eIF2 kinase GCN2
WEK, RONALD C
National Institutes of Health (NIH), National Institute of General Medical Sciences (NIGMS) (ID: 5R01GM049164-24), $392,371USD, 04/01/1993 -- 04/30/2020
 
Translational control during stage conversion of Toxoplasma, an opportunistic infection of HIV/AIDS
SULLIVAN, WILLIAM J and WEK, RONALD C
National Institutes of Health (NIH), National Institute of Allergy and Infectious Diseases (NIAID) (ID: 5R01AI124723-03), $390,875USD, 03/01/2016 -- 02/28/2021
2017
Metabolic stress responses and eIF2 kinase GCN2
WEK, RONALD C
National Institutes of Health (NIH), National Institute of General Medical Sciences (NIGMS) (ID: 5R01GM049164-23), $352,596USD, 04/01/1993 -- 04/30/2020
 
Translational control during stage conversion of Toxoplasma, an opportunistic infection of HIV/AIDS
SULLIVAN, WILLIAM J and WEK, RONALD C
National Institutes of Health (NIH), National Institute of Allergy and Infectious Diseases (NIAID) (ID: 5R01AI124723-02), $389,080USD, 03/01/2016 -- 02/28/2021
2016
Metabolic stress responses and eIF2 kinase GCN2
WEK, RONALD C
National Institutes of Health (NIH), National Institute of General Medical Sciences (NIGMS) (ID: 2R01GM049164-22A1), $388,795USD, 04/01/1993 -- 04/30/2020
 
Translational control during stage conversion of Toxoplasma, an opportunistic infection of HIV/AIDS
SULLIVAN, WILLIAM J and WEK, RONALD C
National Institutes of Health (NIH), National Institute of Allergy and Infectious Diseases (NIAID) (ID: 1R01AI124723-01), $386,080USD, 03/01/2016 -- 02/28/2021
2015
Metabolic stress responses andeIF2 kinase GCN2
WEK, RONALD C
National Institutes of Health (NIH), National Institute of General Medical Sciences (NIGMS) (ID: 3R01GM049164-21S1), $116,099USD, 04/01/1993 -- 05/31/2016
2014
Inhibition of phosphatase activity as a novel treatment for chronic toxoplasmosis
SULLIVAN, WILLIAM J and WEK, RONALD C
National Institutes of Health (NIH), National Institute of Allergy and Infectious Diseases (NIAID) (ID: 5R21AI105786-02), $229,371USD, 08/10/2013 -- 07/31/2016
 
Metabolic stress responses andeIF2 kinase GCN2
WEK, RONALD C
National Institutes of Health (NIH), National Institute of General Medical Sciences (NIGMS) (ID: 5R01GM049164-21), $343,929USD, 04/01/1993 -- 05/31/2016
2013
Inhibition of phosphatase activity as a novel treatment for chronic toxoplasmosis
SULLIVAN, WILLIAM J and WEK, RONALD C
National Institutes of Health (NIH), National Institute of Allergy and Infectious Diseases (NIAID) (ID: 1R21AI105786-01), $183,298USD, 08/10/2013 -- 07/31/2015
 
Metabolic stress responses andeIF2 kinase GCN2
WEK, RONALD C
National Institutes of Health (NIH), National Institute of General Medical Sciences (NIGMS) (ID: 5R01GM049164-20), $331,903USD, 04/01/1993 -- 04/30/2015
2012
Metabolic stress responses andeIF2 kinase GCN2
WEK, RONALD C
National Institutes of Health (NIH), National Institute of General Medical Sciences (NIGMS) (ID: 5R01GM049164-19), $343,953USD, 04/01/1993 -- 04/30/2015
2011
Metabolic stress responses andeIF2 kinase GCN2
WEK, RONALD C
National Institutes of Health (NIH), National Institute of General Medical Sciences (NIGMS) (ID: 2R01GM049164-18A1), $353,588USD, 04/01/1993 -- 04/30/2015
2010
Metabolic stress responses and eIF2 kinase GCN2
WEK, RONALD C
National Institutes of Health (NIH), National Institute of General Medical Sciences (NIGMS) (ID: 5R01GM049164-17), $334,232USD, 04/01/1993 -- 08/14/2011
 
Translational control and latent Toxoplasma infection
SULLIVAN, WILLIAM J and WEK, RONALD C
National Institutes of Health (NIH), National Institute of Allergy and Infectious Diseases (NIAID) (ID: 5R21AI084031-02), $190,575USD, 06/15/2009 -- 05/31/2012
2009
Metabolic stress responses and eIF2 kinase GCN2
WEK, RONALD C
National Institutes of Health (NIH), National Institute of General Medical Sciences (NIGMS) (ID: 5R01GM049164-16), $337,703USD, 04/01/1993 -- 04/30/2011
 
Translational control and latent Toxoplasma infection
SULLIVAN, WILLIAM J and WEK, RONALD C
National Institutes of Health (NIH), National Institute of Allergy and Infectious Diseases (NIAID) (ID: 1R21AI084031-01), $231,000USD, 06/15/2009 -- 05/31/2011
2008
Metabolic stress responses and eIF2 kinase GCN2
WEK, RONALD C
National Institutes of Health (NIH), National Institute of General Medical Sciences (NIGMS) (ID: 5R01GM049164-15), $337,795USD, 04/01/1993 -- 04/30/2011